As of 2026-04-02, the Fair Value of BioNTech SE (BNTX) is -124.13 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 89.42 USD, the upside of BioNTech SE is -238.81%.
With the market price of 89.42 USD and our fair value calculation, BioNTech SE (BNTX) is not a good investment. Investing in BNTX stocks now will result in a potential loss of 238.81%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | 5Y Avg | |
| Net income | 10,293.00 | 9,434.00 | 930.30 | -665.30 | -1,136.10 | 3,771.18 |
| YoY growth | 68,520.00% | -8.35% | -90.14% | -171.51% | -70.77% | 13,635.85% |
| Market Cap (mil) | 23,553.23 |
| P/E | |
| Forward P/E |
| EPS | -4.31 |
| Avg earnings growth rate | 13,635.85% |
| TTM earnings | -1,136.10 |